Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Contreras

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Circulation. Heart Failure|August 27, 2020
Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19Vinh Q Chau, Gennaro Giustino, Kiran Mahmood, et al.
The Journal of Physiology|December 24, 2015
Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814G Mazzocchi, L Sommese, J Palomeque, et al.
The Plant Cell|March 7, 2021
Host-interactor screens of Phytophthora infestans RXLR proteins reveal vesicle trafficking as a major effector-targeted processBenjamin Petre, Mauricio P Contreras, Tolga O Bozkurt, et al.
Science Advances|June 5, 2026
A potato late blight pathogen effector interacts with ENTH-domain protein TOL9a and an activated helper NLR to suppress immunityJogi Madhuprakash, AmirAli Toghani, Hsuan Pai, et al.
Plos Biology|January 19, 2023
Disentangling the complex gene interaction networks between rice and the blast fungus identifies a new pathogen effectorYu Sugihara, Yoshiko Abe, Hiroki Takagi, et al.
Plos Biology|October 18, 2024
Activation of plant immunity through conversion of a helper NLR homodimer into a resistosomeMuniyandi Selvaraj, AmirAli Toghani, Hsuan Pai, et al.
Cardiovascular Drugs and Therapy|June 15, 2023
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without DiabetesMaeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, et al.
Journal of Pediatric Hematology/Oncology|May 19, 2026
A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia ConsortiumLinah Omer, Nicholas J Gloude, Catherine McGuinn, et al.
Journal of the American College of Cardiology|November 16, 2020
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection FractionCarlos G Santos-Gallego, Ariana P Vargas-Delgado, Juan Antonio Requena-Ibanez, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Circulation. Heart Failure|August 27, 2020
Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19Vinh Q Chau, Gennaro Giustino, Kiran Mahmood, et al.
The Journal of Physiology|December 24, 2015
Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814G Mazzocchi, L Sommese, J Palomeque, et al.
The Plant Cell|March 7, 2021
Host-interactor screens of Phytophthora infestans RXLR proteins reveal vesicle trafficking as a major effector-targeted processBenjamin Petre, Mauricio P Contreras, Tolga O Bozkurt, et al.
Science Advances|June 5, 2026
A potato late blight pathogen effector interacts with ENTH-domain protein TOL9a and an activated helper NLR to suppress immunityJogi Madhuprakash, AmirAli Toghani, Hsuan Pai, et al.
Plos Biology|January 19, 2023
Disentangling the complex gene interaction networks between rice and the blast fungus identifies a new pathogen effectorYu Sugihara, Yoshiko Abe, Hiroki Takagi, et al.
Plos Biology|October 18, 2024
Activation of plant immunity through conversion of a helper NLR homodimer into a resistosomeMuniyandi Selvaraj, AmirAli Toghani, Hsuan Pai, et al.
Cardiovascular Drugs and Therapy|June 15, 2023
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without DiabetesMaeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, et al.
Journal of Pediatric Hematology/Oncology|May 19, 2026
A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia ConsortiumLinah Omer, Nicholas J Gloude, Catherine McGuinn, et al.
Journal of the American College of Cardiology|November 16, 2020
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection FractionCarlos G Santos-Gallego, Ariana P Vargas-Delgado, Juan Antonio Requena-Ibanez, et al.
Pageof 15